Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot

Trial Profile

Adjusting infliximab dose in IBD patients in remission, based on infliximab trough levels: the study on Infliximab Levels in IBD patients Steering Treatment, the ILIST pilot

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Infliximab (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Therapeutic Use
  • Acronyms ILIST
  • Most Recent Events

    • 26 Mar 2014 Trial status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 30 Jan 2014 Last checked against Netherlands Trial Register
    • 20 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top